Virus and Antibody Dynamics in Acute West Nile Virus Infection

Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Pl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 2008-10, Vol.198 (7), p.984-993
Hauptverfasser: Busch, Michael P., Kleinman, Steven H., Tobler, Leslie H., Kamel, Hany T., Norris, Philip J., Walsh, Irina, Matud, Jose L., Prince, Harry E., Lanciotti, Robert S., Wright, David J., Linnen, Jeffrey M., Caglioti, Sally
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 993
container_issue 7
container_start_page 984
container_title The Journal of infectious diseases
container_volume 198
creator Busch, Michael P.
Kleinman, Steven H.
Tobler, Leslie H.
Kamel, Hany T.
Norris, Philip J.
Walsh, Irina
Matud, Jose L.
Prince, Harry E.
Lanciotti, Robert S.
Wright, David J.
Linnen, Jeffrey M.
Caglioti, Sally
description Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for $gt; 40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. Results. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for > 40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. Conclusions. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for > 40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components.
doi_str_mv 10.1086/591467
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69522093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>40254224</jstor_id><sourcerecordid>40254224</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-32d67c5d6c6022ee38bb2b48e52d75266821e4dee66894843f6c1d3535d027953</originalsourceid><addsrcrecordid>eNqF0E1r3DAQBmARWpJt2v6DFl_Sm9vR6PtSWNKPBEJKoU1CLkKWZFDqtTeSDd1_Xwcvm2NPGngfhtFLyFsKHylo-UkYyqU6IisqmKqlpOwFWQEg1lQbc0JelfIAAJxJdUxOqFZolGYr8vkm5alUrg_Vuh9TM4Rd9WXXu03ypUp9tfbTGKvbWMbqOnWxWvhl30Y_pqF_TV62rivxzf49Jb-_ff11flFf_fh-eb6-qj1nMNYMg1ReBOnlfFKMTDcNNlxHgUEJlFIjjTzEOE-Ga85a6WlggokAqIxgp-TDsnebh8dpvsZuUvGx61wfh6lYaQQiGPZfiBQ4aoBn6PNQSo6t3ea0cXlnKdinSu1S6Qzf7zdOzSaGZ7bvcAZne-CKd12bXe9TOTgEKRiDJ_ducQ9lHPIh54CCI_I5r5c8lTH-PeQu_7HzGUrYi7t7y29_3pj5o_aa_QOehJKk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21042800</pqid></control><display><type>article</type><title>Virus and Antibody Dynamics in Acute West Nile Virus Infection</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Busch, Michael P. ; Kleinman, Steven H. ; Tobler, Leslie H. ; Kamel, Hany T. ; Norris, Philip J. ; Walsh, Irina ; Matud, Jose L. ; Prince, Harry E. ; Lanciotti, Robert S. ; Wright, David J. ; Linnen, Jeffrey M. ; Caglioti, Sally</creator><creatorcontrib>Busch, Michael P. ; Kleinman, Steven H. ; Tobler, Leslie H. ; Kamel, Hany T. ; Norris, Philip J. ; Walsh, Irina ; Matud, Jose L. ; Prince, Harry E. ; Lanciotti, Robert S. ; Wright, David J. ; Linnen, Jeffrey M. ; Caglioti, Sally</creatorcontrib><description>Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for $gt; 40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. Results. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for &gt; 40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. Conclusions. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for &gt; 40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1086/591467</identifier><identifier>PMID: 18729783</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Acute Disease ; Antibodies ; Antibodies, Viral - blood ; Biological and medical sciences ; Blood ; Blood donation ; Blood Donors ; Blood transfusion ; Disease transmission ; Fundamental and applied biological sciences. Psychology ; Humans ; Infections ; Infectious diseases ; Medical sciences ; Microbiology ; Miscellaneous ; Neutralization Tests ; Nucleic Acid Amplification Techniques ; RNA ; RNA, Viral - blood ; Specimens ; Transfusion Reaction ; Viremia ; Virology ; Viruses ; West Nile Fever - immunology ; West Nile Fever - virology ; West Nile virus ; West Nile virus - immunology ; West Nile virus - isolation &amp; purification</subject><ispartof>The Journal of infectious diseases, 2008-10, Vol.198 (7), p.984-993</ispartof><rights>Copyright 2008 Infectious Diseases Society of America</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-32d67c5d6c6022ee38bb2b48e52d75266821e4dee66894843f6c1d3535d027953</citedby><cites>FETCH-LOGICAL-c430t-32d67c5d6c6022ee38bb2b48e52d75266821e4dee66894843f6c1d3535d027953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/40254224$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/40254224$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>315,781,785,804,27926,27927,58019,58252</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20653303$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18729783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Busch, Michael P.</creatorcontrib><creatorcontrib>Kleinman, Steven H.</creatorcontrib><creatorcontrib>Tobler, Leslie H.</creatorcontrib><creatorcontrib>Kamel, Hany T.</creatorcontrib><creatorcontrib>Norris, Philip J.</creatorcontrib><creatorcontrib>Walsh, Irina</creatorcontrib><creatorcontrib>Matud, Jose L.</creatorcontrib><creatorcontrib>Prince, Harry E.</creatorcontrib><creatorcontrib>Lanciotti, Robert S.</creatorcontrib><creatorcontrib>Wright, David J.</creatorcontrib><creatorcontrib>Linnen, Jeffrey M.</creatorcontrib><creatorcontrib>Caglioti, Sally</creatorcontrib><title>Virus and Antibody Dynamics in Acute West Nile Virus Infection</title><title>The Journal of infectious diseases</title><addtitle>The Journal of Infectious Diseases</addtitle><description>Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for $gt; 40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. Results. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for &gt; 40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. Conclusions. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for &gt; 40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components.</description><subject>Acute Disease</subject><subject>Antibodies</subject><subject>Antibodies, Viral - blood</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Blood donation</subject><subject>Blood Donors</subject><subject>Blood transfusion</subject><subject>Disease transmission</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Neutralization Tests</subject><subject>Nucleic Acid Amplification Techniques</subject><subject>RNA</subject><subject>RNA, Viral - blood</subject><subject>Specimens</subject><subject>Transfusion Reaction</subject><subject>Viremia</subject><subject>Virology</subject><subject>Viruses</subject><subject>West Nile Fever - immunology</subject><subject>West Nile Fever - virology</subject><subject>West Nile virus</subject><subject>West Nile virus - immunology</subject><subject>West Nile virus - isolation &amp; purification</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0E1r3DAQBmARWpJt2v6DFl_Sm9vR6PtSWNKPBEJKoU1CLkKWZFDqtTeSDd1_Xwcvm2NPGngfhtFLyFsKHylo-UkYyqU6IisqmKqlpOwFWQEg1lQbc0JelfIAAJxJdUxOqFZolGYr8vkm5alUrg_Vuh9TM4Rd9WXXu03ypUp9tfbTGKvbWMbqOnWxWvhl30Y_pqF_TV62rivxzf49Jb-_ff11flFf_fh-eb6-qj1nMNYMg1ReBOnlfFKMTDcNNlxHgUEJlFIjjTzEOE-Ga85a6WlggokAqIxgp-TDsnebh8dpvsZuUvGx61wfh6lYaQQiGPZfiBQ4aoBn6PNQSo6t3ea0cXlnKdinSu1S6Qzf7zdOzSaGZ7bvcAZne-CKd12bXe9TOTgEKRiDJ_ducQ9lHPIh54CCI_I5r5c8lTH-PeQu_7HzGUrYi7t7y29_3pj5o_aa_QOehJKk</recordid><startdate>20081001</startdate><enddate>20081001</enddate><creator>Busch, Michael P.</creator><creator>Kleinman, Steven H.</creator><creator>Tobler, Leslie H.</creator><creator>Kamel, Hany T.</creator><creator>Norris, Philip J.</creator><creator>Walsh, Irina</creator><creator>Matud, Jose L.</creator><creator>Prince, Harry E.</creator><creator>Lanciotti, Robert S.</creator><creator>Wright, David J.</creator><creator>Linnen, Jeffrey M.</creator><creator>Caglioti, Sally</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20081001</creationdate><title>Virus and Antibody Dynamics in Acute West Nile Virus Infection</title><author>Busch, Michael P. ; Kleinman, Steven H. ; Tobler, Leslie H. ; Kamel, Hany T. ; Norris, Philip J. ; Walsh, Irina ; Matud, Jose L. ; Prince, Harry E. ; Lanciotti, Robert S. ; Wright, David J. ; Linnen, Jeffrey M. ; Caglioti, Sally</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-32d67c5d6c6022ee38bb2b48e52d75266821e4dee66894843f6c1d3535d027953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acute Disease</topic><topic>Antibodies</topic><topic>Antibodies, Viral - blood</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Blood donation</topic><topic>Blood Donors</topic><topic>Blood transfusion</topic><topic>Disease transmission</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Neutralization Tests</topic><topic>Nucleic Acid Amplification Techniques</topic><topic>RNA</topic><topic>RNA, Viral - blood</topic><topic>Specimens</topic><topic>Transfusion Reaction</topic><topic>Viremia</topic><topic>Virology</topic><topic>Viruses</topic><topic>West Nile Fever - immunology</topic><topic>West Nile Fever - virology</topic><topic>West Nile virus</topic><topic>West Nile virus - immunology</topic><topic>West Nile virus - isolation &amp; purification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Busch, Michael P.</creatorcontrib><creatorcontrib>Kleinman, Steven H.</creatorcontrib><creatorcontrib>Tobler, Leslie H.</creatorcontrib><creatorcontrib>Kamel, Hany T.</creatorcontrib><creatorcontrib>Norris, Philip J.</creatorcontrib><creatorcontrib>Walsh, Irina</creatorcontrib><creatorcontrib>Matud, Jose L.</creatorcontrib><creatorcontrib>Prince, Harry E.</creatorcontrib><creatorcontrib>Lanciotti, Robert S.</creatorcontrib><creatorcontrib>Wright, David J.</creatorcontrib><creatorcontrib>Linnen, Jeffrey M.</creatorcontrib><creatorcontrib>Caglioti, Sally</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Busch, Michael P.</au><au>Kleinman, Steven H.</au><au>Tobler, Leslie H.</au><au>Kamel, Hany T.</au><au>Norris, Philip J.</au><au>Walsh, Irina</au><au>Matud, Jose L.</au><au>Prince, Harry E.</au><au>Lanciotti, Robert S.</au><au>Wright, David J.</au><au>Linnen, Jeffrey M.</au><au>Caglioti, Sally</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Virus and Antibody Dynamics in Acute West Nile Virus Infection</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>The Journal of Infectious Diseases</addtitle><date>2008-10-01</date><risdate>2008</risdate><volume>198</volume><issue>7</issue><spage>984</spage><epage>993</epage><pages>984-993</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for $gt; 40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. Results. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for &gt; 40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. Conclusions. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for &gt; 40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>18729783</pmid><doi>10.1086/591467</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 2008-10, Vol.198 (7), p.984-993
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_69522093
source MEDLINE; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Acute Disease
Antibodies
Antibodies, Viral - blood
Biological and medical sciences
Blood
Blood donation
Blood Donors
Blood transfusion
Disease transmission
Fundamental and applied biological sciences. Psychology
Humans
Infections
Infectious diseases
Medical sciences
Microbiology
Miscellaneous
Neutralization Tests
Nucleic Acid Amplification Techniques
RNA
RNA, Viral - blood
Specimens
Transfusion Reaction
Viremia
Virology
Viruses
West Nile Fever - immunology
West Nile Fever - virology
West Nile virus
West Nile virus - immunology
West Nile virus - isolation & purification
title Virus and Antibody Dynamics in Acute West Nile Virus Infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T09%3A03%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Virus%20and%20Antibody%20Dynamics%20in%20Acute%20West%20Nile%20Virus%20Infection&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Busch,%20Michael%20P.&rft.date=2008-10-01&rft.volume=198&rft.issue=7&rft.spage=984&rft.epage=993&rft.pages=984-993&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1086/591467&rft_dat=%3Cjstor_proqu%3E40254224%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21042800&rft_id=info:pmid/18729783&rft_jstor_id=40254224&rfr_iscdi=true